-

BrainCheck Achieves HITRUST i1 Certification, Demonstrating Commitment to Cybersecurity and Information Protection

HITRUST Certification validates that BrainCheck is meeting rigorous cybersecurity and data protection standards through independent assessment and assurance.

AUSTIN, Texas--(BUSINESS WIRE)--BrainCheck, the leading FDA Class II digital cognitive assessment and care platform, today announced that its BrainCheck Platform, hosted on Amazon Web Services (AWS), has earned HITRUST CSF Certified status for cybersecurity and information protection.

“Achieving HITRUST Certification reinforces our ongoing commitment to protecting data, managing risk, and maintaining the trust of those we serve.” – Bassel Samman, BrainCheck CTO

Share

The HITRUST Certification demonstrates that the BrainCheck Platform has met requirements defined by leading cybersecurity and regulatory frameworks, confirming that strong controls are in place to protect sensitive data and manage risk effectively.

Built on the HITRUST Assurance Program, this achievement reflects independent third-party testing, centralized quality assurance, and certification backed by HITRUST’s Cyber Threat-Adaptive engine. These elements ensure continuous alignment with the latest threat intelligence and evolving standards across NIST, ISO, and OWASP.

“As cybersecurity expectations rise, our stakeholders expect credible, validated assurance,” said Bassel Samman, CTO at BrainCheck. “Achieving HITRUST Certification reinforces our ongoing commitment to protecting data, managing risk, and maintaining the trust of those we serve.”

“Earning HITRUST Certification demonstrates BrainCheck’s commitment to managing information risk and protecting sensitive data through a rigorous, proven assurance process,” said Gregory Webb, CEO of HITRUST. “This achievement reflects the organization’s proactive approach to cybersecurity and trust.”

To learn more, visit www.braincheck.com.

About BrainCheck

BrainCheck is an FDA Class II–cleared digital platform for cognitive assessment and care, used by over 500 healthcare organizations nationwide, including Bon Secours, UPMC, and Springfield Clinic. Clinicians use BrainCheck’s validated screeners and care planning tools to create tailored protocols, completing more than 400,000 cognitive assessments to date. BrainCheck is not intended for use as a stand-alone diagnostic tool.

Contacts

BrainCheck Media Contact
Kate Smith
Senior Marketing Specialist
BrainCheck Inc
kate.smith@braincheck.com

BrainCheck


Release Versions

Contacts

BrainCheck Media Contact
Kate Smith
Senior Marketing Specialist
BrainCheck Inc
kate.smith@braincheck.com

Social Media Profiles
More News From BrainCheck

BrainCheck® Launches Population Analytics to Scale Proactive Cognitive Care

AUSTIN, Texas--(BUSINESS WIRE)--Blood-based biomarkers and disease-modifying therapies are rapidly changing Alzheimer's disease care, but one challenge remains largely unsolved: how do health systems identify which patients should be evaluated first? Today, most patients are identified only during an Annual Wellness Visit (AWV), where cognitive screening competes with dozens of other preventive care requirements. As a result, many patients who may benefit from further evaluation are never ident...

BrainCheck Selected for Three Poster Presentations at the 2026 Alzheimer’s Association International Conference

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--BrainCheck Inc., a cognitive workflow platform, today announced that three of its research submissions have been accepted for poster presentations at the 2026 Alzheimer’s Association International Conference (AAIC), taking place July 12-15 in London, United Kingdom. The accepted abstracts span clinical validation, care planning outcomes, and international adaptation of the BrainCheck platform. AAIC is the world’s largest forum for the dementia research...

Peer-Reviewed Study Design Paper Published for PREDICTOM Alzheimer's Screening Initiative Featuring BrainCheck

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--BrainCheck Inc., a cognitive workflow platform, today highlighted the publication of a peer-reviewed study design paper for PREDICTOM — the large-scale European Alzheimer's early detection initiative in which BrainCheck Assess is serving as a cognitive assessment tool. The paper, published in The Journal of Prevention of Alzheimer's Disease, details the full protocol for a novel AI-driven screening platform designed to bring Alzheimer's diagnostics int...
Back to Newsroom